ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

Open Vet J. 2025; 15(4): 1823-1835


The ameliorative effect of gallic acid and/or Lasix on topiramate-induced renal impairment in male rats

Rana Ramadan, El-Said El-Sherbini, Gehad Elsayed, Mohamed El-Adl.



Abstract
Download PDF Cited by 0 ArticlesPost

Background:
Topiramate (TPM) is commonly used for migraine prophylaxis; nonetheless, it is linked to nephrotoxicity, which mostly results from oxidative stress and inflammatory mechanisms.

Aim:
This study aimed to assess the preventive effects of gallic acid (GA) and furosemide (Lasix) against renal damage caused by TPM in rats.

Methods:
Sixty male albino rats were categorized into six groups: control, TPM-only, TPM + Lasix, Lasix-only, TPM + GA, and GA-only. The investigation lasted 60 days, evaluating renal function, oxidative stress indicators, and histological and immunohistochemical alterations.

Results:
The TPM-treated group exhibited considerable renal impairment, as indicated by increased levels of creatinine, urea, blood urea nitrogen (BUN), and interleukin (IL)-6, as well as reduced activity of antioxidant enzymes (catalase (CAT), superoxide dismutase (SOD)). Histopathological examination revealed tubular necrosis and inflammation, whilst immunohistochemistry results showed elevated expression of caspase3 and IL-6. The co-administration of GA or Lasix mitigated these effects. The TPM+GA group exhibited improved kidney function, less oxidative stress, and enhanced histological structure, underscoring GA's powerful antioxidant and anti-inflammatory characteristics. Likewise, Lasix exerted protective effects by alleviating TPM-induced kidney injury.

Conclusion:
These data highlight the therapeutic efficacy of GA and Lasix against TPM-induced nephrotoxicity, indicating their clinical relevance in addressing drug-induced kidney damage.

Key words: TPM, Gallic acid, Lasix, Renal damage, Anti-inflammatory, Antioxidant







Bibliomed Article Statistics

36
48
25
15
10
20
8
7
R
E
A
D
S

31

87

15

11

10

13

10

13
D
O
W
N
L
O
A
D
S
0506070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.